Parabolic Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.29 M
- Revenue Growth 2.51%
- Profit Growth -51.29%
- Ebitda -27.45%
- Net Worth 36.22%
- Total Assets 56.77%
About Parabolic Lifesciences
Parabolic Lifesciences Private Limited (PLPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 September 2019 (Five years and five months 8 days old ). Its registered office is in Modinagar, Uttar Pradesh, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹7.29 M.
Bharat Singhal and Pooja Agarwal serve as directors at the Company.
Company Details
- Location
Modinagar, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24299UP2019PTC121464
- Company No.
121464
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Sep 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Parabolic Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bharat Singhal  | Director | 20-Sep-2019 | Current |
| Pooja Agarwal | Director | 20-Sep-2019 | Current |
Financial Performance of Parabolic Lifesciences.
Parabolic Lifesciences Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.51% increase. The company also saw a substantial fall in profitability, with a 51.29% decrease in profit. The company's net worth Soared by an impressive increase of 36.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Parabolic Lifesciences?
In 2023, Parabolic Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Indo-Swift Organics Private LimitedBharat Singhal is a mutual person
Charges (Loans)
₹7.29 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 0.63 Cr
- Others : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 May 2024 | Axis Bank Limited | ₹6.30 M | Open |
| 03 Jan 2024 | Others | ₹0.99 M | Open |
How Many Employees Work at Parabolic Lifesciences?
Unlock and access historical data on people associated with Parabolic Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Parabolic Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Parabolic Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
